Evidence map›Paper›PMID 42591002›Full record

ArticleJournal of human nutrition and dietetics : the official journal of the British Dietetic Association2026

Defining Cachexia in Children With Cancer in the United States: Developing a Framework to Inform Clinical and Research Practice.

Daniel V Runco, Guohai Zhou, Adina R Lemeshow, Stephen E Schachterle, Agnieszka Gajewska, Ira Jacobs, Alexandra Palmer, Xunming Sun

Abstract read
In one paragraph

Article in Journal of human nutrition and dietetics : the official journal of the British Dietetic Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel V RuncoDivision of Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0002-1018-9914
Guohai ZhouGlobal Medical Epidemiology, Pfizer Inc, New York, New York, USA.ORCID https://orcid.org/0000-0002-8826-403X
Adina R LemeshowGlobal Medical Epidemiology, Pfizer Inc, New York, New York, USA.ORCID https://orcid.org/0000-0003-2994-1341
Stephen E SchachterleGlobal Medical Epidemiology, Pfizer Inc, New York, New York, USA.ORCID https://orcid.org/0000-0001-6017-2670
Agnieszka GajewskaGlobal Medical Epidemiology, Pfizer Polska, Warsaw, Poland.ORCID https://orcid.org/0009-0007-7675-1803
Ira JacobsFormerly Pfizer Research and Development, Pfizer Inc, New York, New York, USA.ORCID https://orcid.org/0000-0001-8350-7760
Alexandra PalmerPfizer Research and Development, Pfizer Inc, New York, New York, USA.
Xunming SunGlobal Medical Epidemiology, Pfizer Inc, New York, New York, USA.ORCID https://orcid.org/0009-0003-4663-4471

Funding

Pfizer
6 · The paper itself

Abstract

backgroundCancer cachexia describes the muscle and weight loss, anorexia, and physical impairment common in certain adult cancers. No formal criteria exist to define paediatric cancer cachexia, making its clinical recognition and impact largely unknown. Using established undernutrition guidelines, criteria were developed to identify potential cachexia in children with cancer based on standardised anthropometric measures or diagnostic codes.

methodsThe Surveillance, Epidemiology, and End Results and Optum Electronic Health Records databases were used to estimate prevalence and incidence rates of cancer and cancer cachexia between 2017 and 2021 in patients aged < 20 and < 18 years, respectively. In the absence of a consensus definition for paediatric cachexia, four sets of candidate criteria were developed based on body weight for length/height or body mass index z-scores, or reduced gain or loss of body weight, corresponding to mild or severe undernutrition. A fifth criterion required a potentially cachexia-related ICD-10-CM diagnosis code.

resultsThis study included 26,855 paediatric patients (aged < 18 years) with cancer; ~90% were aged ≥ 2 years. Epidemiologic estimates for cancer cachexia prevalence and incidence rate varied considerably by age, cancer type and cachexia definition. Estimates were low for most categories, especially in the youngest age groups; however, cachexia was difficult to assess in patients aged < 2 years due to small patient numbers.

conclusionsWe describe one of the first attempts to develop potential paediatric cachexia criteria. These criteria and resulting data provide a framework to inform further research into generating consensus guidelines for the identification of childhood cancer cachexia.

Indexed as

CachexiaNeoplasmsAdolescentBody Mass IndexBody WeightChildChild, PreschoolFemaleHumansIncidenceInfantMaleMalnutritionPrevalenceSEER ProgramUnited Statescachexiacancerchildrenmalnutritionpaediatricweight loss

Identifiers

PMID42591002
PMCPMC13470151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.